Anthony B. Hodsman

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Robert M. Neer, Claude D. Arnaud, José Zanchetta et al. · New England Journal of Medicine · 2001 · 4.6K citations

Medicine, Endocrinology, Bone Metabolism +16

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

A. Papaioannou, Suzanne N. Morin, Angela M. Cheung et al. · Canadian Medical Association Journal · 2010 · 1.8K citations · Full text

Medicine, Endocrinology, Preventive Medicine +12

Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis

Jonathan D. Adachi, W. Bensen, Jacques P. Brown et al. · New England Journal of Medicine · 1997 · 694 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis

Jean‐Jacques Body, Gregory Gaich, Wim H. Scheele et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 365 citations

Medicine, Pharmacotherapy, Bone Augmentation +16

Enhancement of Bone Mass in Osteoporotic Women with Parathyroid Hormone followed by Alendronate¹

Roger S. Rittmaster, Michael A. Bolognese, Mark P. Ettinger et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 308 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16